Cargando…

High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis

BACKGROUND: A low plasma level of high-density lipoprotein (HDL) cholesterol (HDL-C) is associated with cardiovascular risk. A key cardioprotective property of HDL is cholesterol efflux capacity (CEC), the ability of HDL to accept cholesterol from macrophages. In this study, we aimed to identify the...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Chengfeng, Zhao, Xiang, Zhou, Quan, Zhang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681808/
https://www.ncbi.nlm.nih.gov/pubmed/29126414
http://dx.doi.org/10.1186/s12944-017-0604-5
_version_ 1783277985731706880
author Qiu, Chengfeng
Zhao, Xiang
Zhou, Quan
Zhang, Zhen
author_facet Qiu, Chengfeng
Zhao, Xiang
Zhou, Quan
Zhang, Zhen
author_sort Qiu, Chengfeng
collection PubMed
description BACKGROUND: A low plasma level of high-density lipoprotein (HDL) cholesterol (HDL-C) is associated with cardiovascular risk. A key cardioprotective property of HDL is cholesterol efflux capacity (CEC), the ability of HDL to accept cholesterol from macrophages. In this study, we aimed to identify the predictive value of CEC for cardiovascular risk. METHODS: The relative risks (RRs) and 95% confidence intervals (CIs) were pooled to analyze the association between CEC and the incidence of cardiovascular events and all-cause mortality. The odds ratios (ORs) and 95% CIs were pooled to estimate the association of CEC and the prevalence of cardiovascular events. RESULTS: A total of 15 studies were included. Results showed that the highest CEC was significantly associated with a reduced risk of cardiovascular events incidents compared to the lowest CEC (RR, 0.56; 95% CI, 0.37 to 0.85; I (2), 89%); the pooled RR of cardiovascular risk for per unit SD increase was 0.87 (95% CI, 0.73 to 1.04; I (2), 67%). Dose-response curve indicated that cardiovascular risk decreased by 39% (RR, 0.61; 95% CI, 0.51 to 0.74) for per unit CEC increase. Similarly, an inverse association was observed between CEC and the prevalence of cardiovascular events (highest vs. lowest, OR, 0.30; 95% CI, 0.17 to 0.5; I (2) = 63%; per unit SD increase, OR, 0.94; 95% CI, 0.90 to 0.98; I (2) = 71%). However, based on the current data, CEC was not significantly associated with all-cause mortality. CONCLUSIONS: Findings from this meta-analysis suggest that HDL-mediated CEC is inversely associated with cardiovascular risk, which appears to be independent of HDL concentration. The growing understanding of CEC and its role in cardiovascular risk decrease may improve the accuracy of cardiovascular risk prediction and also open important avenues to develop novel therapeutic targeting HDL metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi: 10.1186/s12944-017-0604-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5681808
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56818082017-11-17 High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis Qiu, Chengfeng Zhao, Xiang Zhou, Quan Zhang, Zhen Lipids Health Dis Research BACKGROUND: A low plasma level of high-density lipoprotein (HDL) cholesterol (HDL-C) is associated with cardiovascular risk. A key cardioprotective property of HDL is cholesterol efflux capacity (CEC), the ability of HDL to accept cholesterol from macrophages. In this study, we aimed to identify the predictive value of CEC for cardiovascular risk. METHODS: The relative risks (RRs) and 95% confidence intervals (CIs) were pooled to analyze the association between CEC and the incidence of cardiovascular events and all-cause mortality. The odds ratios (ORs) and 95% CIs were pooled to estimate the association of CEC and the prevalence of cardiovascular events. RESULTS: A total of 15 studies were included. Results showed that the highest CEC was significantly associated with a reduced risk of cardiovascular events incidents compared to the lowest CEC (RR, 0.56; 95% CI, 0.37 to 0.85; I (2), 89%); the pooled RR of cardiovascular risk for per unit SD increase was 0.87 (95% CI, 0.73 to 1.04; I (2), 67%). Dose-response curve indicated that cardiovascular risk decreased by 39% (RR, 0.61; 95% CI, 0.51 to 0.74) for per unit CEC increase. Similarly, an inverse association was observed between CEC and the prevalence of cardiovascular events (highest vs. lowest, OR, 0.30; 95% CI, 0.17 to 0.5; I (2) = 63%; per unit SD increase, OR, 0.94; 95% CI, 0.90 to 0.98; I (2) = 71%). However, based on the current data, CEC was not significantly associated with all-cause mortality. CONCLUSIONS: Findings from this meta-analysis suggest that HDL-mediated CEC is inversely associated with cardiovascular risk, which appears to be independent of HDL concentration. The growing understanding of CEC and its role in cardiovascular risk decrease may improve the accuracy of cardiovascular risk prediction and also open important avenues to develop novel therapeutic targeting HDL metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi: 10.1186/s12944-017-0604-5) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-10 /pmc/articles/PMC5681808/ /pubmed/29126414 http://dx.doi.org/10.1186/s12944-017-0604-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Qiu, Chengfeng
Zhao, Xiang
Zhou, Quan
Zhang, Zhen
High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
title High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
title_full High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
title_fullStr High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
title_full_unstemmed High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
title_short High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
title_sort high-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681808/
https://www.ncbi.nlm.nih.gov/pubmed/29126414
http://dx.doi.org/10.1186/s12944-017-0604-5
work_keys_str_mv AT qiuchengfeng highdensitylipoproteincholesteroleffluxcapacityisinverselyassociatedwithcardiovascularriskasystematicreviewandmetaanalysis
AT zhaoxiang highdensitylipoproteincholesteroleffluxcapacityisinverselyassociatedwithcardiovascularriskasystematicreviewandmetaanalysis
AT zhouquan highdensitylipoproteincholesteroleffluxcapacityisinverselyassociatedwithcardiovascularriskasystematicreviewandmetaanalysis
AT zhangzhen highdensitylipoproteincholesteroleffluxcapacityisinverselyassociatedwithcardiovascularriskasystematicreviewandmetaanalysis